Potent In Vitro and In Vivo Activity of Plantibody Specific for Porphyromonas gingivalis FimA.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26865596)

Published in Clin Vaccine Immunol on April 04, 2016

Authors

Young-Suk Choi1, Ji-Hoi Moon2, Tae-Geum Kim3, Jin-Yong Lee4

Author Affiliations

1: Department of Maxillofacial Biomedical Engineering, School of Dentistry, and Institute of Oral Biology, Kyung Hee University, Seoul, Republic of Korea Department of Dental Hygiene, Shinsung University, Chungnam, Republic of Korea.
2: Department of Maxillofacial Biomedical Engineering, School of Dentistry, and Institute of Oral Biology, Kyung Hee University, Seoul, Republic of Korea Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea prudence75@khu.ac.kr ljinyong@khu.ac.kr.
3: Department of Molecular Biology and the Institute for Molecular Biology and Genetics, Chonbuk National University, Jeonju, Republic of Korea.
4: Department of Maxillofacial Biomedical Engineering, School of Dentistry, and Institute of Oral Biology, Kyung Hee University, Seoul, Republic of Korea ljinyong@khu.ac.kr.

Articles cited by this

Mechanisms of phagocytosis in macrophages. Annu Rev Immunol (1999) 9.66

Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet (2004) 7.84

Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev (1998) 6.28

The isolation and characterization of murine macrophages. Curr Protoc Immunol (2008) 4.86

Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun (1995) 4.33

Subgingival microflora and periodontal disease. J Clin Periodontol (1979) 3.69

Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med (1998) 3.11

Production of antibodies in transgenic plants. Nature (1989) 2.78

Passive antibody therapy for infectious diseases. Nat Rev Microbiol (2004) 2.64

Phagocytosis and innate immunity. Curr Opin Immunol (2002) 2.47

Generation and assembly of secretory antibodies in plants. Science (1995) 2.45

Specific inhibition of adherence of an oral strain of Bacteroides gingivalis 381 to epithelial cells by monoclonal antibodies against the bacterial fimbriae. Arch Oral Biol (1988) 2.39

Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun (1998) 2.27

Molecular cloning and sequencing of the gene encoding the fimbrial subunit protein of Bacteroides gingivalis. J Bacteriol (1988) 2.25

Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection. J Clin Invest (2013) 2.15

Interactions of Porphyromonas gingivalis with epithelial cells. Infect Immun (1993) 2.12

A novel mouse model to study the virulence of and host response to Porphyromonas (Bacteroides) gingivalis. Infect Immun (1991) 2.07

Synthetic peptides analogous to the fimbrillin sequence inhibit adherence of Porphyromonas gingivalis. Infect Immun (1992) 1.90

Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction. Infect Immun (1992) 1.82

Porphyromonas (Bacteroides) gingivalis fimbrillin: size, amino-terminal sequence, and antigenic heterogeneity. Infect Immun (1991) 1.67

Porphyromonas gingivalis traffics to autophagosomes in human coronary artery endothelial cells. Infect Immun (2001) 1.65

Distribution of Porphyromonas gingivalis strains with fimA genotypes in periodontitis patients. J Clin Microbiol (1999) 1.58

Purification, characterization and immunolocalization of fimbrial protein from Porphyromonas (bacteroides) gingivalis. Biochem Biophys Res Commun (1991) 1.54

Porphyromonas gingivalis invades oral epithelial cells in vitro. J Periodontal Res (1993) 1.52

Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Emerg Infect Dis (2002) 1.51

Salivary receptors for recombinant fimbrillin of Porphyromonas gingivalis. Infect Immun (1994) 1.36

Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants. Eur J Immunol (1994) 1.24

The importance of fimbriae in the virulence and ecology of some oral bacteria. Oral Microbiol Immunol (1998) 1.20

Detection of specific antibodies against fimbriae and membrane proteins from the oral anaerobe Bacteroides gingivalis in patients with periodontal diseases. Microbiol Immunol (1987) 1.19

Identification of a new variant of fimA gene of Porphyromonas gingivalis and its distribution in adults and disabled populations with periodontitis. J Periodontal Res (2002) 1.16

The acute inflammatory response and the role of phagocytic cells in periodontal health and disease. Periodontol 2000 (1997) 1.14

Polymorphonuclear neutrophils and their mediators in gingival tissues from generalized aggressive periodontitis. J Periodontol (2001) 1.12

Distribution and molecular characterization of Porphyromonas gingivalis carrying a new type of fimA gene. J Clin Microbiol (2000) 1.12

Microbiology of periodontal diseases: introduction. Periodontol 2000 (2005) 1.10

Role of superoxide dismutase in resistance of Porphyromonas gingivalis to killing by polymorphonuclear leukocytes. Infect Immun (1992) 1.08

Purification of major fimbrial proteins of Porphyromonas gingivalis. Protein Expr Purif (1995) 1.05

Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens. Infect Immun (2005) 1.05

Prevalence of fimA genotypes of Porphyromonas gingivalis and periodontal health status in Chinese adults. J Periodontal Res (2007) 0.94

Active and passive immunity, vaccine types, excipients and licensing. Occup Med (Lond) (2007) 0.90

Porphyromonas gingivalis FimA fimbriae: fimbrial assembly by fimA alone in the fim gene cluster and differential antigenicity among fimA genotypes. PLoS One (2012) 0.89

The role of osteoimmunology in periodontal disease. Biomed Res Int (2013) 0.88

A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune response. Vaccine (2011) 0.87

In vitro invasion and survival of Porphyromonas gingivalis in gingival fibroblasts; role of the capsule. Arch Immunol Ther Exp (Warsz) (2012) 0.87

A comparison of IgG antibody reactive with Bacteroides forsythus and Porphyromonas gingivalis in adult and early-onset periodontitis. J Periodontol (1997) 0.85

Genotype analysis of Porphyromonas gingivalis fimA in Korean adults using new primers. J Med Microbiol (2012) 0.84

Effect of enamel matrix derivative on periodontal ligament cells in vitro is diminished by Porphyromonas gingivalis. J Periodontol (2004) 0.84

Microbial interactions with neutrophils. Rev Infect Dis (1983) 0.84

Synthesis and assembly of an adjuvanted Porphyromonas gingivalis fimbrial antigen fusion protein in plants. Protein Expr Purif (2005) 0.82

E-selectin mediates Porphyromonas gingivalis adherence to human endothelial cells. Infect Immun (2012) 0.81

High level of expression of recombinant human granulocyte-macrophage colony stimulating factor in transgenic rice cell suspension culture. Biotechnol Bioeng (2003) 0.79

Cloning and characterization of heavy and light chain genes encoding the FimA-specific monoclonal antibodies that inhibit Porphyromonas gingivalis adhesion. Microbiol Immunol (2011) 0.79

Synthesis and assembly of Porphyromonas gingivalis fimbrial protein in potato tissues. Mol Biotechnol (2009) 0.78

Characterization of FimA in Porphyromonas gingivalis genotype IV. FEMS Immunol Med Microbiol (2012) 0.77

Production of Monoclonal Antibodies Specific to FimA of Porphyromonas gingivalis and Their Inhibitory Activity on Bacterial Binding. Immune Netw (2009) 0.77

Generation of specific antibody-secreting cells in salivary glands of BALB/c mice following parenteral or oral immunization with Porphyromonas gingivalis fimbriae. Arch Oral Biol (1993) 0.76

Articles by these authors

In Vitro Effects of Polyphosphate against Prevotella intermedia in Planktonic Phase and Biofilm. Antimicrob Agents Chemother (2015) 0.75